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To all of us who worry too much at times.

ABSTRACT
Background: Worry is common among both adolescents and adults, and exces-
sive worry is related to a number of mental health problems. Current pharmaco-
logical and psychological treatments for worry are moderately effective, and the 
processes involved in therapeutic change remain unclear. Building on theories 
of excessive worry could be a way forward in developing more streamlined and 
effective treatments. This thesis mainly concerns itself with two theories of worry: 
the intolerance of uncertainty model and the metacognitive model.
Aim: The overall aim of this thesis was to develop and evaluate streamlined psy-
chological interventions for adolescents and adults, specifically targeting hypoth-
esized causal mechanisms relevant in the maintenance of excessive worry. More 
specifically, the aims were (1) to develop a streamlined intolerance of uncertainty-
focused treatment (IU-CBT) for adolescents with excessive worry, and explore its 
feasibility and preliminary efficacy in face-to-face and online-delivered formats, 
(2) to explore the experiences of the adolescents and their parents who had received 
online IU-CBT with parental involvement, and (3) to develop internet-delivered 
metacognitive therapy for adult worriers (I-MCT), evaluate its clinical efficacy, 
and explore the mediating effects of negative beliefs about worry in treatment.
Methods: Four studies (I-IV) were conducted within this doctoral project. To 
evaluate the feasibility and preliminary efficacy of face-to-face IU-CBT for ado-
lescents, we conducted study I, an uncontrolled pilot feasibility trial (N = 12). The 
treatment protocol was subsequently transformed into an online version and its 
feasibility and preliminary efficacy was evaluated in a pilot feasibility study with 
a multiple-baseline design (N = 13; study II). In study III, eight adolescents and 
nine parents who had participated in study II were interviewed in a qualitative 
study and data were analyzed using thematic analysis. Study IV was a randomized 
controlled trial with mediation analysis where adult excessive worriers (N = 108) 
were randomized to either I-MCT or a wait-list control condition.
Results: In study I, there were no drop-outs or adverse events, and most fami-
lies described high treatment satisfaction. The results showed large reductions 
in self-rated worry and secondary outcomes, and the effects were maintained at 
three-months follow-up. In study II, all but one adolescent followed through with 
the online treatment, and treatment module completion rates were high. We found 
medium to large reductions in self-rated worry, anxiety, depressive symptoms, and 
impaired functioning at post-treatment and the changes were maintained at one 
and three-month follow-ups. Study III showed that even though the online format 
posed challenges to the families and many would have appreciated some addi-
tional therapist-support, online IU-CBT for adolescents with excessive worry can 
be acceptable for both the adolescents and their parents. Exposure to uncertainty 
could be difficult but was also experienced as worthwhile and both adolescents 
and parents described the parental involvement in treatment as important for the 
adolescents’ treatment adherence. In study IV, treatment retention was high and 
I-MCT appeared to be acceptable to patients. Change in negative beliefs about 
worry mediated change in worry (more so than did change in depression), and 
large effects favoring I-MCT were observed. Effects were maintained after six 
and twelve months.
Conclusions: An IU-focused treatment for adolescents with excessive worry is 
feasible and potentially effective, when delivered face-to-face as well as online. 
I-MCT is also acceptable and effective for adults with excessive worry. Change 
in negative beliefs about worry appear to mediate change in worry outcomes 
in I-MCT, or put differently: if one does not believe that worry is dangerous or 
uncontrollable, one worries less. In conclusion, the findings lend further support 
to intolerance of uncertainty and negative beliefs about worry being promising 
treatment targets in novel interventions for excessive worry.
SAMMANFATTNING
Bakgrund: Oro är vanligt hos både ungdomar och vuxna och överdriven oro 
förekommer ofta i samband med psykisk ohälsa. Aktuella farmakologiska och 
psykologiska behandlingar har måttlig effekt på oro och exakt hur förändring vid 
psykologisk behandling går till är fortfarande okänt. Att utgå från vetenskapliga 
teorier om överdriven oro skulle kunna vara ett sätt att utveckla fokuserade och 
effektiva behandlingar. Denna avhandling utgår i första hand från två teorier för 
överdriven oro: intolerans för osäkerhetsmodellen och den metakognitiva modellen.
Syfte: Det övergripande syftet med denna avhandling var att utveckla och utvärdera 
fokuserade psykologiska behandlingar med särskilt fokus på mekanismer som even-
tuellt bidrar till överdriven oro hos ungdomar och vuxna. Avhandlingens specifika 
syften var (1) att utveckla en behandling (IU-KBT) som fokuserar på att minska 
intolerans för osäkerhet hos ungdomar med överdriven oro, och undersöka dess 
genomförbarhet och preliminära kliniska effekter när behandlingen ges på tradi-
tionellt sätt (ansikte-mot-ansikte) samt via internet, (2) att utforska hur ungdomarna 
och deras föräldrar som genomgått IU-KBT via internet upplevde behandlingen 
samt (3) att utveckla internetförmedlad metakognitiv terapi (I-MCT) för vuxna 
med överdriven oro, utvärdera dess kliniska effekt samt undersöka om förändring 
av negativa uppfattningar om oro medierar förändring av oro under behandlingen.
Metod: Fyra studier (I-IV) genomfördes inom ramen för detta doktorandprojekt. 
För att utvärdera genomförbarheten och den preliminära effekten av IU-KBT 
ansikte-mot-ansikte genomförde vi studie I, en pilotstudie utan kontrollgrupp 
(N = 12). Behandlingsprotokollet omvandlades därefter till en internetversion och 
dess genomförbarhet och preliminära effektivitet utvärderades i en pilotstudie med 
multipel baslinjedesign (N = 13; studie II). I studie III, en kvalitativ studie, gjordes 
djupintervjuer med åtta ungdomar och nio föräldrar som hade deltagit i studie II 
och data analyserades med hjälp av tematisk analys. Studie IV var en randomis-
erad kontrollerad studie med mediationsanalys där vuxna med överdriven oro (N 
= 108) randomiserades till antingen I-MCT eller väntelista.
Resultat: Alla patienter i studie I genomförde behandlingen, inga negativa effekter 
rapporterades och de flesta familjer uppgav att de var nöjda. Resultaten visade 
stora effekter på självskattad oro och sekundära utfallsmått, och effekterna bibe-
hölls tre månader efter avslutad behandling. I studie II genomförde alla utom en 
tonåring behandlingen och antalet genomförda behandlingsmoduler var högt för 
både ungdomar och deras föräldrar. Vi fann medelstora till stora effekter på ung-
domarnas oro, ångest, depressiva symtom och nedsatt funktion efter behandlin-
gen och förändringarna bibehölls vid en och tre månaders uppföljning. Studie III 
visade att även om formatet innebar utmaningar för många, och flera hade önskat 
lite mer behandlarstöd, var internetförmedlad IU-KBT acceptabel för både ung-
domarna och deras föräldrar. Exponering för osäkerhet beskrevs som utmanande 
men upplevdes också som värdefull och både ungdomar och deras föräldrar beskrev 
att föräldrarnas parallella spår i behandlingen var viktigt för att ungdomarna skulle 
kunna genomföra behandlingen. Även i studie IV genomförde en stor andel av 
deltagarna behandlingen. Stora behandlingseffekter för I-MCT (jämfört med vän-
telista) observerades och bibehölls vid sex och tolv månader. Förändring i negativa 
uppfattningar om oro medierade förändring i oro.
Slutsatser: En IU-fokuserad behandling för ungdomar med överdriven oro 
tycks vara så väl genomförbar som potentiellt effektiv. I-MCT verkar också vara 
acceptabel och effektiv för vuxna med överdriven oro. Förändring i negativa upp-
fattningar om oro tycks mediera förändring i oro, eller annorlunda uttryckt: om 
man slutar tro att oron är farlig eller okontrollerbar oroar man sig också mindre. 
Sammanfattningsvis ger resultaten stöd för att fokusera på intolerans för osäkerhet 
och negativa uppfattningar om oro i nya behandlingar för överdriven oro.
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11 INTRODUCTION
Life can be full of reasons to worry, both big and small. Currently, the world is 
facing great challenges like the impact of climate change, the extinction of spe-
cies, and social unrest (e.g. Díaz et al., 2019; Evans, 2019; Safi, Tom, & Jones, 
2019). Despite the global community agreeing on the Paris Climate Accord and 
the Global Sustainability Goals in 2015 (the same year I started preparing for this 
doctoral thesis), most of our common problems are not closer to being solved today 
(United Nations, 2019; World Meteorological Organization, 2019). 
Many of us, both adolescents and adults, worry about the future of the planet 
(Burke, Sanson, & Van Hoorn, 2018; Leiserowitz et al., 2019; Ojala, 2012), but 
while worry is a normal human response to uncertainty, challenges, and threats, the 
worrying itself can become an additional burden. Irrespective of what the worry is 
about (be it personal matters such as everyday performance and social evaluative 
stressors, or our global challenges), excessive worrying can impair us, make us 
paralyzed or hostile, or keep us focused on problems rather than facilitate solutions. 
It may also lead to suffering and be related to additional mental health problems. 
In my clinical practice, I have often found excessive worry to be challenging to 
treat. The occurrence of worry may not be something the average person (and 
perhaps some clinicians) would instinctively view as a problem in need of treat-
ment. Excessive worriers often just get on with things, but may do so feeling quite 
miserable. Others may be so focused on the topics of their worry that they do not 
identify the worrying itself as the problem. This somewhat peripheral position of 
worry amongst the anxiety symptoms is largely reflected by standard treatment 
packages for anxiety that include a broad range of interventions targeting a number 
of symptoms. These are often moderately effective and can be difficult to work 
with for both patients and clinicians. 
Perhaps a greater focus on worry itself could streamline treatments and facilitate 
treatment evaluation. If that is in fact the case, how it should be done and if it 
may further our understanding of excessive worry are some of the questions this 
thesis aimed to address.
Stockholm, January 2020.
22 BACKGROUND
2.1 What is worry?
Worry is a psychological phenomenon, characterized by intrusive thoughts about 
potential negative outcomes and accompanied by anxiety (Macleod, Williams, & 
Bekerian, 1991). The worrier often poses internal “what if”-questions about future 
threats (Borkovec, 1985), and while worrying can be associated with adaptive 
problem-focused coping strategies, it often involves both unsuccessful problem-
solving attempts, negative intrusive thoughts and somatic anxiety responses 
(Davey, Hampton, Farrell, & Davidson, 1992; Szabo & Lovibond, 2002). Despite 
its association with negative affect, worrying seems difficult to dismiss for the 
worrier (Mathews, 1990), and the process is often perceived as hard to control 
(Borkovec, Robinson, Pruzinsky, & DePree, 1983; Hirsch & Mathews, 2012; 
Wells & Carter, 2001). 
Worry occurs from early in life, with children as young as five years old reporting 
worry (Vasey, Crnic, & Carter, 1994). The prevalence of worry increases with age, 
with older children and adolescents worrying more than younger children (Chorpita, 
Tracey, Brown, & Collica, 1997; Muris, Merckelbach, Gadet, & Moulaert, 2000). 
Among children, almost 70% worry about a number of things (Muris et al., 2000; 
Orton, 1982), and adults without any anxiety disorder have been found to worry 
daily (Dupuy, Beaudoin, Rhéaume, Ladouceur, & Dugas, 2001). Among older 
adults in a cross-sectional study, almost 80% reported worrying, and 37% found 
the worry excessive (Golden et al., 2011). However, older adults have been found 
to worry less than their younger counterparts (Gonçalves & Byrne, 2013). Women 
report more worry than men (Dugas, Freeston, & Ladouceur, 1997; Robichaud, 
Dugas, & Conway, 2003), and data indicate the same for girls compared to boys 
(Campbell & Rapee, 1994; Muris, Meesters, & Gobel, 2001; Silverman, La Greca, 
& Wasserstein, 1995).
2.2 The impact of worry
In addition to being common in the general population, worry is also prevalent in 
a range of mental health problems. Excessive worry about several topics, events, 
or activities is the core symptom in Generalized Anxiety Disorder (GAD) accord-
ing to the Diagnostic and statistical manual of mental disorders (5th ed.; DSM-5; 
American Psychiatric Association, 2013). To fulfill criteria for GAD, the worry 
must be long lasting, impairing, and be perceived as difficult to control by the 
individual. It should also be accompanied by physical or cognitive symptoms (e.g., 
impaired concentration, muscle tension, or sleep disturbance). Children must expe-
rience at least one such physical/cognitive symptom, adults three. The 12-month 
3prevalence for GAD is about 1.0% for 9 to 12 year-olds, 1.5% in adolescence and 
2.1% for adults (Copeland, Angold, Shanahan, & Costello, 2014; Grant, Hasin, 
Stinson, & Dawson, 2005).
Research with children and adolescents finds that those with anxiety disorders 
(including GAD) do not differ from clinical and normal controls in terms of 
worry content but for the frequency and intensity of worry (Perrin & Last, 1997). 
Similarly, adults with GAD tend to worry about the same things as individuals 
without the disorder (Ruscio & Borkovec, 2004). However, those with GAD worry 
more often, have more negative thoughts and beliefs about their worry, and are 
more functionally impaired than those without the disorder (Ruscio & Borkovec, 
2004; Wells & Carter, 2001). Importantly, and as described above, individuals 
without GAD or any other psychiatric disorder also suffer from excessive worry. 
One study (Ruscio, 2002) found that a majority of high worriers met none or just 
one of the four major DSM-IV criteria for GAD (APA, 2000). Subthreshold GAD 
is twice as common as the disorder itself, with subthreshold sufferers experienc-
ing impaired functioning, and frequent use of primary health care services and 
benzodiazepines (Haller, Cramer, Lauche, Gass, & Dobos, 2014).
Excessive worry is a prominent symptom or associated feature of all the anxi-
ety disorders, trauma and obsessive compulsive-related disorders, depression, 
and common in individuals suffering from a wide range of psychiatric disorders 
including autism, psychosis, and eating disorders (to name a few) (Chelminski 
& Zimmerman, 2003; Olatunji, Wolitzky-Taylor, Sawchuk, & Ciesielski, 2010; 
Starcevic, 1995). Research points to worry playing a significant role in the devel-
opment and maintenance of several depressive and anxiety related conditions as 
well as in persecutory delusions (Calmes & Roberts, 2007; Freeman et al., 2015; 
Holeva, Tarrier, & Wells, 2001; Hong, 2007; Muris, Roelofs, Meesters, & Boomsma, 
2004; Newman & Llera, 2011). Individuals (including adolescents) who report 
high levels of worry report lower levels of social support (Kertz, Bigda-Peyton, 
Rosmarin, & Björgvinsson, 2012) and more frequent suicidal thoughts (Boden, 
Fergusson, & Horwood, 2007). In addition, excessive worry is associated with 
poorer social adjustment, and increased risk of a range of physical conditions (often 
beginning in adolescence) including but not limited to, irritable bowel syndrome 
(Bengtson, Aamodt, Vatn, & Harris, 2015; Gerson et al., 2015), pre-natal distress 
and pre-eclampsia in pregnant women (Krishnamurti, Davis, & Simhan, 2019), 
and cardiovascular disease and early mortality (Batelaan, ten Have, van Balkom, 
Tuithof, & de Graaf, 2014; Kubzansky et al., 1997). 
42.3 Previous clinical approaches to excessive worry 
Psychosocial treatments that identify worry as the primary problem, and prioritize 
worry-reduction interventions, have mainly focused on individuals with GAD. 
Of course, psychosocial treatments for other anxiety or anxiety-related disorders 
(PTSD, OCD) and depression often included interventions for worry but not as a 
primary focus of treatment.  Therefore, the following (brief) review of the treat-
ment literature covers studies specifically focusing on individuals with GAD.  
2.3.1 Pharmacological treatments
While the efficacy of various pharmacological agents has been evaluated in indi-
viduals with GAD as a primary or secondary anxiety disorder (Slee et al., 2019), 
the most frequently evaluated agents are selective serotonin reuptake inhibitors 
(SSRIs) and selective serotonin norepinephrine reuptake inhibitors (SSNRIs). In 
respect of children and adolescents, two recent meta-analyses found that such 
drugs yield effect sizes in the moderate range for clinician-rated GAD severity 
compared to placebo (Strawn, Welge, Wehry, Keeshin, & Rynn, 2015; Wang et 
al., 2017). Similar effect sizes relative to placebo are found for these same agents 
in adults with GAD (Slee et al., 2019; Van Ameringen, Patterson, Turna, Pipe, & 
Nakua, 2017). Guidelines on the treatment of childhood anxiety disorders (includ-
ing youth with comorbid GAD) will usually recommend cognitive behavioral 
therapy (CBT) as the first line treatment but a combination of SSRIs plus CBT 
for those who do not respond (e.g. Katzman et al., 2014). In adults, SSRI’s and 
CBT are both recommended as first line treatments for GAD in several guidelines 
(Katzman et al., 2014; National Institute for Health and Care Excellence, 2019; 
Socialstyrelsen, 2017). 
Notably, the evidence for the combination of CBT and antidepressants such as 
SSRI’s as either superior to one single treatment, or as a second-hand alternative for 
non-responders to either treatment alone is limited (Van Ameringen et al., 2017). 
For youth, one study compared CBT, SSRI’s and the combination of both. Results 
were comparable for the mono-therapies, and effects of the combination-therapy 
were better post-treatment (Walkup et al., 2008). However, the combination seemed 
to benefit especially the most severe cases, the study lacked a placebo-plus-CBT 
control, and the combination of CBT and SSRI’s was not more effective than either 
mono-therapy at follow-up (Piacentini et al., 2014). For adults, one study offered 
CBT for patients already receiving anti-depressants and found not additional effect 
of the combination treatment (Crits-Christoph et al., 2011).
52.3.2 Psychological treatments
The GAD-specific, psychological treatment that has received the most empirical 
support are various versions of multi-component CBT programs (Cuijpers et al., 
2014). These programs will use various interventions to treat excessive worry, 
muscle tension, sleep disturbances, avoidance behaviors, reassurance-seeking and 
other interpersonal difficulties, and deficits in problem-solving ability/confidence 
(among other symptoms) (Clementi & Alfano, 2014; Newman, Llera, Erickson, 
Przeworski, & Castonguay, 2013). 
GAD-specific treatments for use with children and adolescents are relatively new 
(discussed below). Since the identification of overanxious disorder (the childhood 
precursor to GAD) in DSM-III (American Psychiatric Association, 1980) and the 
subsequent modification of the GAD criteria to include children in DSM-IV (APA, 
1994), CBT programs have been developed and evaluated for use with youth who 
have multiple anxiety disorders, including GAD (Kendall, 1994; Rapee, 2000). 
These “any anxiety” or generic CBT programs for childhood anxiety disorder have 
been shown to be effective compared to waitlist (59% vs 17% remission rates 
from one or more of the comorbid anxiety disorders) but with average effect sizes 
for CBT in the moderate range at post-treatment and follow-up (James, James, 
Cowdrey, Soler, & Choke, 2015). Few trials have been carried out comparing 
generic CBT for anxiety programs to another active treatment with little evidence 
for the superiority of CBT (James et al., 2015). 
An advantage of these generic CBT for childhood anxiety programs is that they 
can be delivered with relatively equal effect in a number of formats (i.e., indi-
vidual, group, family), as well as in self-help/bibliotherapy and internet formats, 
i.e. internet-delivered cognitive behavioral therapy (ICBT; Jolstedt, Wahlund, et 
al., 2018; Rapee et al., 2017; Schwartz, Barican, Yung, Zheng, & Waddell, 2019; 
Vigerland et al., 2016). However, it is important to point out that outcomes for 
GAD specifically are not usually reported in trials of generic CBT for childhood 
anxiety disorder. Instead, outcome is indexed as the change in the average of the 
clinician severity ratings for the individual comorbid anxiety disorders and/or 
whether the child has experienced remittance from one or more of their comorbid 
disorders. Also, scores on continuous measures of trait anxiety, depression, and 
behavior problems are often assessed, but not so for measures of worry. Hudson 
et al. (2015) pooled data from several different studies of a generic CBT program 
for childhood anxiety disorders (Cool Kids) and found that a baseline diagnosis 
GAD predicted better outcomes than a diagnosis of social anxiety disorder (SAD). 
However, over 40% of the youth with an initial diagnosis of GAD still met criteria 
for this condition at follow-up (Hudson et al., 2015). This finding is consistent with 
those reported for the efficacy of generic programs for remission from ‘any anxiety 
disorder’, i.e. about 40-50% of treated youth retain one or more of the comorbid 
anxiety disorders they had at the start of treatment, usually some combination of 
GAD, SAD and separation anxiety disorder (James et al., 2015). 
6For adults, a larger number of clinical trials have explored versions of GAD-specific 
CBT. These treatment packages often include a number of interventions such as 
cognitive restructuring, exposure, relaxation training and bio-feedback (Cuijpers 
et al., 2014). Psychological treatments for GAD in adults have been tested in dif-
ferent treatment formats, such as group therapy (Stanley, Beck, & Glassco, 1996; 
Stanley et al., 2003), self-help interventions (Bowman, Scogin, Floyd, Patton, 
& Gist, 1997), and via the internet (Andersson et al., 2012; Dahlin et al., 2016; 
Robinson et al., 2010; Titov et al., 2009). Internet-delivered CBT for adult GAD 
has shown large effects compared to wait-list controls (Richards, Richardson, 
Timulak, & McElvaney, 2015). A meta-analysis evaluated the efficacy of CBT 
for adults with GAD and found that while effect-sizes were large, almost half of 
patients did not respond to treatment (Cuijpers et al., 2014). 
2.4 A complementary approach to excessive worry
Given the central role of worry in GAD and a number of other mental health prob-
lems, and the moderate treatment effects of current interventions, there is room for 
further treatment development. A complementary approach to many of the broad-
based CBT packages could be to develop streamlined treatments specifically target-
ing the worry-process, based on psychological theories for excessive worry. Such 
an approach has been suggested as a way of increasing our understanding of how 
psychological treatments work and improve their outreach and efficacy (Holmes 
et al., 2018; Kazdin, 2007; Kazdin, 2017). In recent years, a number of theories 
aiming to explain why some people (both adolescents and adults) tend to worry 
excessively, and what mechanisms are involved in the maintenance of excessive 
worry have been developed (e.g. Andersson et al., 2017; Behar, DiMarco, Hekler, 
Mohlman, & Staples, 2009; Newman & Llera, 2011). 
This thesis mainly concerns itself with two theories of excessive worry; the intoler-
ance of uncertainty model (Dugas, Gagnon, Ladouceur, & Freeston, 1998) and the 
metacognitive model of worry (Wells, 1995). At the time of planning this doctoral 
project, studies had shown promising results for IU-based treatments for adoles-
cents (Léger, Ladouceur, Dugas, & Freeston, 2003; Payne, Bolton, & Perrin, 2011) 
and one more was underway (Perrin, Bevan, Payne, & Bolton, 2019). Therefore 
an IU-approach was chosen for work with adolescents. At the same time, studies 
of metacognitive therapy (MCT) had shown to be effective in reducing worry in 
adults, and more so than other treatments (van der Heiden, Muris, & van der Molen, 
2012; Wells et al., 2010), why that approach was chosen for adult worriers. These 
theories and their empirical support are described below.
72,4.1 The intolerance of uncertainty model
The intolerance of uncertainty model (IUM; see Figure 1) was originally devel-
oped to explain excessive worry in individuals with GAD (Dugas et al., 1998). It 
is based on the proposition that these individuals have an intolerance of uncertainty 
(IU), meaning that they find uncertain situations stressful and difficult to toler-
ate, and that they react to uncertainty with excessive worry, however unlikely the 
negative outcome really is. 
Figure 1. The intolerance of uncertainty model. Adapted from “Generalized anxiety disor-
der: A preliminary test of a conceptual model”, by Dugas, Gagnon, Ladouceur & Freeston, 
1998, Behaviour Research and Therapy, 36(2), page 216. Copyright (1998) by Elsevier. 
Adapted with permission.
The IU model also includes other processes suggested to contribute to excessive 
worry. According to the model, individuals with GAD hold positive beliefs about 
worry, meaning they believe that worrying will help them prevent or prepare for 
negative events. The worry also leads to increased negative affect, which in turn 
leads to a negative view on problems and one’s ability to solve them (i.e. nega-
tive problem orientation), and a tendency to try to suppress or avoid thoughts (i.e. 
cognitive avoidance), further reinforcing the worry and anxiety. 
While IU is not postulated to be a sole causal factor of worry and anxiety, it is sug-
gested to be related to the development of both excessive worry and other mental 
health problems (Shihata, McEvoy, Mullan, & Carleton, 2016). Meta-analyses 
have shown strong positive correlations between IU and worry in both children, 
8adolescents and adults (Gentes & Ruscio, 2011; Kertz & Woodruff-Borden, 2012; 
Osmanağaoğlu, Creswell, & Dodd, 2018). According to some earlier studies, IU 
and the other constructs within the IU-model have unique relationships with worry 
in GAD (Buhr & Dugas, 2006; Dugas et al., 1998), but subsequent research has 
shown that IU is also strongly related to other psychiatric symptoms and disor-
ders (Carleton, 2012, 2016; Osmanağaoğlu et al., 2018). A number of clinical and 
experimental studies have explored if IU causally effects a range of mental health 
problems (for a review, see Rosser, 2019) with findings suggesting that change in 
IU mediate change in worry in the treatment of adult GAD. Additionally, levels 
of worry were higher when IU was increased through experimental manipulation 
(Bomyea et al., 2015; Ladouceur, Gosselin, & Dugas, 2000). 
A CBT procotol for adults with GAD is based on the IUM and over the last two 
decades, this protocol has been evaluated in several studies. The treatment has 
been shown to be superior to waitlist, (Ladouceur et al., 2000) and equal to or more 
effective than other active treatments (Dugas et al., 2010; Gosselin, Ladouceur, 
Morin, Dugas, & Baillargeon, 2006). One study compared IU-CBT to MCT 
(described below), and found both to be effective, but MCT superior in reducing 
worry (van der Heiden et al., 2012).  IU-CBT has also been delivered in group 
formats with large effect sizes compared to WL (Dugas et al., 2003). One study 
compared IU-CBT to MCT (described below), and found both to be effective, but 
MCT superior in reducing worry (van der Heiden et al., 2012).
As mentioned above, treatments for youth with GAD and/or excessie worry have 
mainly been generic, targeting a number of symptoms and disorders simultaneously. 
However, a handful of treatments based on the IU-model have been developed and 
evaluated for children and/or adolescents. One pilot study evaluated IU-CBT for 
seven adolescents with GAD, aged 16-18 (Léger et al., 2003). After treatment, one 
participant had dropped out while three showed clinically significant change. The 
remaining three were minimally or moderately improved. Based on these results 
and the authors’ suggestions for enhancing the treatment manual, Payne and col-
leagues replicated the results in a pilot-trial with 16 participants, aged 7-17 years 
old (Payne et al., 2011). At post-treatment, 81% no longer met diagnostic criteria for 
GAD and 59% no longer had any comorbid diagnosis. In a randomized pilot trial 
(n=40), the treatment based on the IU model was compared to waitlist, and large 
between-group differences for remission and secondary outcomes (e.g. worry) in 
favor of the IU treatment were found, with 80% no longer meeting GAD criteria 
post-treatment compared to 0% in the WL-group (Perrin et al., 2019). 
92.4.2 The metacognitive model
In the metacognitive model of worry (MCM; Wells, 1995, see Figure 2), beliefs about 
worry (as being dangerous, uncontrollable and/or helpful) are of particular importance 
to the maintentance of the symptom. The MCM divides the worry into two types; 
type 1 worries which are general worries about themes such as external situations or 
physical symptoms (e.g. “what if I make a mistake at work” or “what if I get sick”), 
and type 2 worry which is worry about the worrying itself, (e.g., “I won’t be able to 
focus at work if I don’t stop worrying,” or “I will get sick from all this worrying”). 
According to the MCM, type 2 worry is activated because the individual holds nega-
tive beliefs about the worry (i.e., the worry is uncontrollable or dangerous).
According to the MCM, type 2 worry is associated with ineffective strategies such 
as reassurance seeking, checking behaviors, thought suppression, distraction, and 
avoidance that aim to avoid worry. The strategies are ineffective in reducing worry 
and may decrease learning opportunities when individuals do not learn that they 
can handle both worrisome situations and their own worries, and ultimately lead 
to reinforced beliefs about worry being uncontrollable and/or dangerous. However, 
individuals also often hold positive beliefs about the worry (e.g. “worry helps me 
prepare for negative events”) that also drive the worrying. 
Figure 2. The metacognitive model. Adapted from Cognitive therapy of anxiety disorders: 
A practice manual and conceptual guide (p. 204) by A. Wells, 1997. Copyright (1997) by 
John Wiley & Sons Inc. Adapted with permission. 
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Cross-sectional and longitudinal studies of the constructs underlying the metacog-
nitive model have found associations between metacognitive beliefs and exces-
sive worry (Behar et al., 2009). Negative beliefs about worry have been shown to 
predict worry severity following experimentally induced worry, everyday worry, 
and anxiety over time (Fergus & Wheless, 2018; Ryum et al., 2017; Thielsch, 
Andor, & Ehring, 2015). Change in metacognitive beliefs has also been found to 
precede change in symptoms of both anxiety and depression in a clinical study of 
mixed anxiety and depression (Newby, Williams, & Andrews, 2014). Some results 
indicate that these phenomena are specific for individuals with GAD while oth-
ers have pointed to similar levels of positive and negative beliefs about worry in 
other psychiatric conditions, e.g. obsessive compulsive disorder and panic disorder 
(Cartwright-Hatton & Wells, 1997; Wells & Carter, 2001). 
Metacognitive therapy (MCT) is based on the MCM and has been been evaluated 
for a number of mental health conditions, among them GAD (Normann & Morina, 
2018). The treatment has shown to effectively reduce worry in adults with GAD 
compared to wait-list and active comparators (Nordahl et al., 2018; van der Heiden 
et al., 2012; Wells et al., 2010). One pilot study has also evaluted the efficacy of 
group-based MCT for children aged 7-13 with GAD, with large within group 
effect-sizes on worry (Esbjørn, Normann, Christiansen, & Reinholdt-Dunne, 2018). 
2.5 Conclusions
In conclusion of this brief background, worry is common in the general population 
and excessive worry is often related to mental health problems. Standard pharma-
cological and psychological treatments of excessive worry are moderately effective. 
In order to improve outcomes, we need to further our understanding of the pro-
cesses involved in excessive worry, and develop effective and scalable treatments.
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3 AIMS OF THE THESIS
The overall aim of this thesis was to develop and evaluate streamlined psychological 
interventions specifically targeting hypothesized causal mechanisms relevant in the 
maintenance of excessive worry. In this thesis, I have focused on two theoretical 
approaches; the IUM in the treatment for adolescents with excessive worry, and 
the MCM in the treatment for adults with excessive worry.
3.1 Study I: Face-to-face pilot study (adolescents)
The aim of study I was to develop a streamlined protocol for an IU-focused psy-
chological treatment for adolescents with excessive worry (IU-CBT; described 
below) and to evaluate its feasibility and potential efficacy.
3.2 Study II: Online pilot study (adolescents)
The aim of study II was to expand the treatment protocol from study I to a scalable, 
online format and to evaluate its feasibility and preliminary efficacy. Furthermore, 
we aimed to evaluate whether changes in self-rated worry occurred only after the 
introduction of the intervention, thus indicating a causal effect of the intervention.
3.3 Study III: Qualitative interviews (about study II)
The aim of study III was to explore the experiences of the adolescents and parents 
who had participated in study II. More specifically, we wanted to explore how they 
experienced the program itself (e.g., the treatment content and working indepen-
dently with exposure) and the collaborations during treatment (i.e., between the 
adolescents and the parents, as well as with their therapists).
3.4 Study IV: Randomized trial with mediation  
analysis (adults)
The aims of study IV were to evaluate the clinical efficacy of internet-delivered 
metacognitive therapy (I-MCT; described below) for adult excessive worriers, and 
to explore if change in negative beliefs about worry mediated change in excessive 
worry, and if such mediation depended on the baseline severity of these beliefs. 
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4 EMPIRICAL STUDIES
4.1 The treatments
This thesis covers the development and evaluation of two treatment protocols. The 
first targets excessive worry in adolescents aged 13-17 years old (studies I-III). 
The second treatment is designed for adults with excessive worry (study IV). The 
treatments are described below.
4.1.1 Intolerance of uncertainty treatment for adolescents
For adolescents, we developed a treatment based on the IU theory (Dugas et al., 
1998), IU-CBT. The treatment was developed in two stages and was evaluated as a 
face-to-face treatment in study I, and as an online intervention in study II. IU-CBT 
was directed towards both the adolescent suffering from excessive worry and (at 
least) one of the adolescent’s parents or legal guardians (hereinafter referred to 
as parents). The treatment was intended to increase the adolescent’s tolerance to 
uncertainty and change their behavioral approach towards uncertainty. That means, 
helping adolescents see that their usual ways of handling uncertainty through 
control and/or avoidance was ineffective and reinforced worry, and then encour-
aged them to expose themselves to uncertain thoughts and situations. The parallel 
parent program had three main aims: to provide psychoeducation about worry, to 
change parental behaviors related to worry when needed, and to encourage the 
parent to support the adolescent through treatment. Interventions specifically tar-
geting processes other than IU, suggested to be of importance to the maintenance 
of excessive worry (such as negative problem orientation and positive beliefs 
about worry; Dugas et al., 1998) were not included in IU-CBT. Cognitive avoid-
ance was targeted in treatment, but exposure to thoughts was framed as a way of 
increasing tolerance to uncertainty rather than as a way of achieving habituation 
to thoughts related to uncertainty. 
In study I, the intervention was provided to the adolescents in-person by a clinical 
psychologist. The adolescents received up to 12 individual sessions during a 12 
week treatment period. During the treatment, the parents worked with an online-
delivered parent program consisting of five modules (a new module was opened 
every other week during the first nine weeks of the treatment). During the treatment 
period, the parents had contact with a therapist (the same therapist who treated 
the adolescent) via an encrypted digital platform for support, help with problem 
solving and clarifications when needed. 
For study II, the treatment protocol from study I was transformed into an online 
version where both the adolescents and the parents received all of the treatment 
material in ten modules via the internet platform. The intervention can be described 
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as an online book, with each module similar to a chapter, containing a number 
of pages with short texts, illustrations, video-clips, and instructions to homework 
assignments. The modules also included worksheets that the participants filled 
in and the therapists reviewed and commented on. Both the adolescents and the 
parents were encouraged to work with one treatment module each week, and after 
completing one module, they get access to the next. Both the adolescents and the 
parents had asynchronous (email like) contact with a therapist (the same for the 
adolescent and the parent) via the internet-platform.
Figure 3. Screenshot of a page from module 1 in IU-CBT delivered via the internet 
(i.e. “BIP Worry”) in study II.
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Figure 4. Screenshot of a worksheet from module 7 in IU-CBT delivered via the internet 
(i.e. “BIP Worry”) in study II. “Skriv här” is Swedish for “Type here”.
4.1.2 Metacognitive treatment for adults
For adults, we developed an internet-delivered metacognitive treatment (I-MCT). 
The treatment protocol was based on a book chapter about metacognitive therapy 
for GAD (Wells, 2011). The main aim of the intervention was to change patients’ 
beliefs about worry (in particular negative beliefs such as worry being dangerous 
or uncontrollable) in order to reduce excessive worry. I-MCT included a number 
of exercises and experiments that the participant planned together with a therapist 
and then conducted and evaluated. Furthermore, the participant practiced attention 
exercises supposed to help thwart their metacognitive beliefs. Positive beliefs and 
unhelpful coping behaviors related to worry were also targeted in I-MCT. 
The participants worked with eight treatment modules delivered via a secure treat-
ment platform during a ten week period. After having completed one module, they 
got access to the next. The modules mainly consisted of text material presented 
in PDF files (about 60 pages) and audio files with instructions to practical exer-
cises. The participants had asynchronous contact with a therapist via the treatment 
platform, and the therapists normally responded within 24 hours on week days. 
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4.2 The studies
4.2.1 Study I: Intolerance of uncertainty-focused treatment for 
adolescents with excessive worry – a pilot feasibility study
4.2.1.1 Methods
Study I was a pilot feasibility study that included 12 adolescents (13-17 years old) 
with excessive worry. The main inclusion criteria was scoring >21 points on the 
Penn State Worry Questionnaire for Children (PSWQ-C; Chorpita et al., 1997) and 
participants were included irrespective of psychiatric diagnosis. Each participant 
had at least one parent or legal guardian co-participate with them in the study. The 
adolescents were assessed by a psychologist before and after 12 weeks of IU-CBT 
and at a three-month follow-up, and they completed self-assessments of worry (the 
PSWQ-C) and related cognitive processes weekly during the treatment. Parents also 
reported on the adolescents’ levels of worry, anxiety and depression. Patient satis-
faction, treatment credibility, adverse events related to the treatment, and parental 
accommodation to anxiety were also assessed. We calculated within-group effects 
on worry and secondary measures using ANOVAs with post-hoc analyzes, and 
calculated clinically significant change and reliable change indexes (Jacobson & 
Truax, 1991) to assess the number of participants who improved after treatment.
4.2.1.2 Main results
All participants remained in the study, and no serious adverse events were reported. 
The adolescents attended 9-12 individual sessions (M = 10.5) and parents completed 
4-5 internet-delivered modules (M = 4.6). Most families described high treatment 
satisfaction and credibility. Of the 12 adolescents, nine achieved a reliable change 
in self-rated worry at post-treatment and seven did so at follow-up. On a group 
level, the results showed significant changes in self-rated worry with a large effect 
size (d = 2.0; p < .001). Self-reported anxiety and impaired functioning were also 
significantly reduced after treatment, as were parent-reported worry and impaired 
functioning. Parents’ accommodation to their adolescents’ worry was also reduced 
after treatment. These effects were all maintained at follow-up.
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4.2.2 Study II: Online cognitive behavior therapy for adolescents with 
excessive worry – a multiple baseline design feasibility study
4.2.2.1 Methods
Study II was a multiple baseline design feasibility evaluation of an online version 
of IU-CBT (“BIP Worry”). It included 13 adolescents (13-17 years old) and at 
least one of their parents. Before commencing the treatment, the adolescents were 
randomized to different baseline assessment periods; two, six or ten weeks long. 
During the baseline periods, the adolescents completed the Brief PSWQ (Topper, 
Emmelkamp, Watkins, & Ehring, 2014) as a self-assessment of worry every week. 
The point of using a baseline phase was to insert an element of control over time, 
maturation and spontaneous recovery in this small feasibility study. The adoles-
cents were assessed by a psychologist before the baseline-phase, after treatment 
and at one and three-month follow-ups. Pre-baseline, pre- and post-treatment, and 
at both follow-ups, adolescents also completed the full version of the PSWQ-C 
(Chorpita et al., 1997). In addition to measuring symptoms of worry, anxiety and 
depression, we assessed impaired functioning, any negative effects of treatment, 
treatment credibility and client satisfaction. Multi-level linear mixed models were 
used to estimate mean effects and we used visual inspection to evaluate how the 
introduction of BIP Worry affected individual levels of worry.
4.2.2.2 Main results
Of the thirteen adolescents initially included, one dropped out during the first 
week of treatment and the rest remained in the study. Both the adolescents and 
their parents who followed through with treatment completed on average 9.8 of 
the ten treatment modules and client satisfaction and treatment credibility were 
high. We could not show a casual effect of the intervention through the multiple 
baseline design but on a group level, we found medium to large reductions in 
self-rated worry (on the PSWQ-C), anxiety, depressive symptoms, and impaired 
functioning at post-treatment (d = 0.69-1.38; p = .001). Similar changes for worry, 
anxiety and depression were reported by the parents (d = 0.49-1.76; p = .001) and 
the changes were maintained at one- and three-month follow-ups. Therapist time 
averaged 21 minutes per family (adolescent and parent) and week.
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4.2.3 Study III: Experiences of online exposure-based treatment 
with parental support for teenagers with excessive worry.
4.2.3.1 Methods
Study III was a qualitative exploration of adolescents’ and parents’ experiences 
of the online version of IU-CBT (“BIP Worry”). We invited all adolescents and 
parents from study II to participate in qualitative interviews. Of these, eight ado-
lescents and nine parents accepted. Each participant (adolescents and parents alike) 
received one cinema ticket as compensation for their participation. The interviews 
were based on an interview schedule and were conducted by a clinical psycholo-
gist who had not been involved in study II. All interviews were audio recorded 
and transcribed verbatim by the interviewer. Based on the transcriptions, we used 
thematic analysis (Braun & Clarke, 2006) to code the data and categorize the codes 
into main themes and subthemes. 
4.2.3.2 Main results
The data was categorized into two main themes (“Seeing the worry in a new light” 
and “Freedom with responsibility”) which both were divided into three subthemes. 
The treatment content helped many of the adolescents and parents understand the 
worrying better. Exposure to uncertainty was experienced as worthwhile even 
though it was challenging and both adolescents and parents described the parental 
involvement in treatment as important for the adolescents’ treatment adherence. 
For some families, the parental involvement also had a positive impact on their 
relationship. Overall, the findings suggested that an online treatment for adolescents 
with excessive worry can be acceptable for both the adolescents and their parents, 
even though the online format posed challenges to many and several described 
having appreciated more therapist support. 
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4.2.4 Study IV: Are negative beliefs about worry driving exces-
sive worry? A randomized controlled trial of metacognitive 
therapy with mediation analysis
4.2.4.1 Methods 
Study IV was a randomized controlled trial with mediation analysis. We included 
108 excessive worriers aged ≥18 years who were randomized to either I-MCT or 
a waitlist control condition (WL). Before inclusion in the study, inclusion/exclu-
sion criteria and diagnostic status were assessed via telephone by a psychology 
master student under supervision. During the intervention, all contact between 
the participants and the therapists was via the internet. The participants reported 
level of worry, negative beliefs about worry and depressive symptoms weekly 
during I-MCT and WL, at post-treatment and at six and twelve months follow-
up. Depression, cognitive avoidance, and emotional contrast avoidance were 
also assessed pre- and post-treatment, and at follow-up. Occurrences of adverse 
events during treatment were reported at post-treatment. We used univariate and 
multivariate latent growth curve models to assess the effects of treatment and the 
mediators, and participants were assessed as responders at post-treatment if their 
levels of worry were reduced by at least 9 points on the PSWQ (Meyer, Miller, 
Metzger, & Borkovec, 1990).
4.2.4.2 Main results
The findings supported our hypothesis that changes in negative beliefs about worry 
would mediate change in worry post-treatment (ab = -0.908, 95% CI [-1.537, 
-0.458]), and significantly more so than changes in depressive symptoms (p = 
.003). The effect of changes in negative beliefs on worry did not depend on the 
severity of these beliefs at baseline, meaning that participants with higher levels 
of negative beliefs about worry did not have a better treatment outcome than those 
with lower. The analyses showed that participants in the I-MCT group had a sig-
nificantly larger reduction in worry compared to the WL group (d = 1.64), and 
there was a higher responder rate (74% vs. 7%) in the I-MCT group. The attrition 
rate was low (3.7% at post-treatment), as were number of reported adverse events.
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4.3 Ethical considerations
Ethical considerations must influence researchers on every level of the scientific 
process. Participation in research should generally not expose participants to greater 
risk of harm than normal life would, and all research should be considered from 
the standpoint of the research participants (The British Psychological Society, 
2014). The studies included in this thesis were all approved by the regional ethics 
committee in Stockholm, Sweden, and further steps were taken in order to ensure 
ethical scientific processes throughout the studies.
Studies I-III involved adolescents (and their parents). Research questions regard-
ing young people are important, as needs of children and adolescents may differ 
from those of adults (Modi et al., 2014). However, children must never be included 
in research against their will due to pressure from a parent or other person in a 
position of power. When recruiting participants to studies I-III, we discussed the 
importance of the adolescent’s consent with each family, and underlined that 
they could decline participation even if the parent was positive to inclusion in the 
trial. As previous clinical studies for adolescents with excessive worry are scarce, 
we did not want to put more participants than necessary through treatment if it 
showed to be unfeasible for families, or appeared to be ineffective in reducing 
worry. Therefore, we conducted pilot feasibility trials before initiating any larger 
trials of IU-CBT. 
Furthermore, we conducted a qualitative exploration, (i.e. study III) in order to 
improve our understanding of the adolescents’ perspectives on IU-CBT. Importantly, 
some ethical aspects specific to qualitative research should be considered. Quotes 
from the in-depth interviews facilitate understanding of individual experiences of 
treatment, but because they are rich and descriptive in nature, they may pose a threat 
to the confidentiality of the informants (Haverkamp, 2005). In order to minimize 
that risk, we chose the quotes carefully and shortened them when possible so that 
they would not convey any more information than necessary. Furthermore, par-
ticipants could potentially feel coerced to participate in study III as they had been 
given a free (and for some quite effective) treatment by the same people who later 
asked them to engage in the interviews. While we cannot rule out that this hap-
pened, we attempted to decrease the risk of anyone feeling forced to participate 
by having an independent psychologist being in contact with the informants in 
study III, rather than someone who had been involved in study II.
Thorough assessments prior to inclusion in the clinical trials were intended to 
increase safety and minimize harm. It ensured that participants with health care 
needs not addressed in our trials (e.g. severe depression, eating disorders or sui-
cidality) were referred to other health care providers. We also tracked potential 
adverse events, and symptoms such as depression and suicidality for all partici-
pants in studies I, II and IV. 
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Studies I, II, and IV all included clinical research via the internet. Participants’ 
personal information should always be treated with confidentiality, but research 
conducted via the internet places a particular importance on information security 
(The British Psychological Society, 2017). To ensure the confidentiality of all data, 
we used double authentication procedures on the internet treatment platforms. In 
study IV, we did not meet participants face-to-face in initial interviews prior to 
inclusion as we did in studies I and II, and thus could not detect any non-verbal 
hesitation or prompt further questions. To ensure valid consent, information about 
the study was therefore also given by an interviewer during the pre-treatment tel-
ephone assessment, and participants were invited to ask questions. 
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5 DISCUSSION
The overall aim of this thesis was to develop and evaluate streamlined psychologi-
cal interventions specifically targeting hypothesized causal mechanisms relevant 
to the maintenance of excessive worry, drawn from the intolerance of uncertainty 
model (IUM) as applied to adolescents, or from the metacognitive model (MCM) 
as applied to adults.
5.1 Summary of the findings
Before starting study I, we were not sure that the adolescents and their parents 
would appreciate the treatment rationale and engage with a treatment focusing 
narrowly on exposure to uncertainty. Previous research indicated that children and 
adolescents with GAD could be engaged in face-to-face treatment where expo-
sure to uncertainty was one of several interventions designed to target the four 
processes in the IU (Dugas et al., 1998) either alone (Leger et al., 2003; Payne et 
al, 2011; and later Perrin et al, 2019) or alongside interventions targeting perfec-
tionism (Holmes et al., 2014). Clinically, it made sense to hone in on IU, which 
numerous studies have found to be very strongly correlated with the severity of 
worry in youth (for a review, see: Osmanağaoğlu et al., 2018). The results from 
studies I and II suggested that the participants and their parents could engage with 
both the treatment rationale and the exposure to uncertainty. Furthermore, IU-CBT 
appeared to be effective in reducing worry, both when delivered in-person and 
via the internet, with symptoms of anxiety and depression also being significantly 
reduced at post-treatment, and with uncontrolled effect sizes comparable to previ-
ous trials evaluating the efficacy of the full IU model-based treatment with youth 
(Léger et al., 2003; Payne et al., 2011; Perrin et al., 2019). 
In addition to the rationale and primary treatment component, we were uncertain 
whether the treatment would be acceptable when delivered in an online format. 
Previous qualitative research has found internet-delivered treatments for youth 
to be acceptable (for a review, see: McCashin, Coyle, & O’Reilly, 2019), but the 
evaluated treatments tend to involve multiple components or interventions. If the 
adolescent or parent could not engage with the IU focus, and there was not many 
other interventions to work with in the internet-delivered treatment, would they 
drop-out or be dissatisfied? Informants in study III described the online-treatment as 
demanding but acceptable, they understood the rationale and felt that it was mostly 
relevant to them and their experiences. They did not complain about the treatment 
lacking interventions that were more relevant to their experience of worry, on the 
contrary, some even found certain parts of the treatment redundant despite our 
efforts to streamline it. Additionally, we found that many (both adolescents and 
parents), appreciated the parental involvement, which they thought helped facilitate 
treatment adherence – specifically facing up to situations involving uncertainty.  
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Studies I and II did not include control groups, which limits causal inferences about 
IU-CBT. Instead, we used a multiple baseline design to control for maturation and 
natural variation in worry in study II, but the findings did not show a causal effect 
of the intervention. In hindsight, I believe that this could be due (at least in part) to 
the outcome measure (the Brief PSWQ; Topper et al., 2014). We used it because it 
only contains five items, and we did not want to burden the participants more than 
necessary during the baseline and intervention phases. However, the Brief PSWQ is a 
screening measure and may be insensitive to changes in worry during treatment. Had 
we used the PSWQ-C (Chorpita et al., 1997), which has been shown to be sensitive 
to the effects of treatment (e.g., Perrin et al., 2019), during the baseline- and treat-
ment phases, a different set of findings may have emerged in study II.  The results 
of studies I and II are by nature preliminary and need to be replicated, preferably 
using the PSWQ-C with larger samples and under randomized controlled conditions. 
The findings from the mediation analysis in study IV supported the hypothesis that 
reductions in worry during I-MCT with excessive worriers were at least partly medi-
ated by a reduction in negative beliefs about worry, and more so than by reductions 
in depressive symptoms as a comparator mediator. Interestingly, the hypothesis 
that participants with higher levels versus lower levels of negative beliefs about 
worry would benefit more from I-MCT was not supported. This could be due to 
restriction of range, i.e. that there were very few participants who did not hold 
beliefs about worries being dangerous or uncontrollable. However, it might also 
be true that individuals who do not hold such beliefs are not as bothered by and 
do not seek treatment for excessive worry, at least via the internet. 
The findings from study IV suggest that changes in negative beliefs about worry may 
be an important change mechanism in I-MCT with excessive worriers. However, 
mediator effects as tested in study IV are correlational in nature, and while they 
can point to possible change mechanisms, additional design features and assump-
tions must be met before inferences about causality can be drawn in clinical trials 
(Kazdin, 2007). N-of-1 trials with frequent and repeated (daily) measurement of 
the putative mediators and outcome variable could help to more clearly establish 
order effects, i.e. that changes in negative beliefs about worry precede changes 
in worry severity, or with reversals (i.e., reinstatement of negative beliefs about 
worry), to help establish causality. Future studies could also randomize participants 
to three conditions, with each providing different dosages of the interventions 
designed to target the proposed change mechanism (i.e. negative beliefs about 
worry). If outcomes varied in the expected direction across the three conditions, 
this would suggest a dose-response relationship, lending further support for the 
causal impact of these beliefs on excessive worry. 
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While this is only one trial, the results of study IV suggest that I-MCT was feasi-
ble, acceptable, and effective for adults with excessive worry who were recruited 
online. Importantly, the therapy was delivered with the aid of therapists who were 
masters-level students, all novices to MCT, and with no financial- or intellectual 
conflicts of interests (i.e. low level of allegiance effects). Participants completed 
a relatively high proportion of the treatment modules (mean number of com-
pleted modules was 5.6 out of 8) and there were few drop-outs. Both worry and 
symptoms of anxiety and depression were significantly reduced at post-treatment 
compared to the participants randomized to the wait-list. The controlled effect 
sizes were comparable or close to those from previous studies of MCT delivered 
in the face-to-face format with adults suffering from excessive worry (Nordahl et 
al., 2018; van der Heiden et al., 2012; Wells et al., 2010). That the treatment was 
feasible, acceptable, and effective when delivered in an internet format with the 
aid of MCT-inexperienced therapists, is an important finding given the emphasis 
placed on the need for advanced training when delivering MCT (Wells, 2011). 
Again, further studies are needed before firm conclusions can be drawn about the 
acceptability and efficacy of I-MCT. 
5.2 Are the findings important?
Though the effect sizes in the outcome trials in this thesis were mostly in the mod-
erate to large range, the response and remission rates were not significantly greater 
than previously found using traditional, multi-component, cognitive behavioral 
interventions for worry. So, in what way are the findings important? 
First, the streamlined approach used in study I, II and IV offers what could be termed 
relatively ‘high-resolution images’ of the patients and their specific trajectories 
through treatment. That is, instead of providing a large number of different inter-
ventions, and hoping that patients would have the time and energy to learn and use 
them all, we streamlined the treatment to focus on a few major themes, and then 
evaluated the therapeutic effects of that streamlined treatment. This approach can 
help guide clinicians and researchers alike to consider what are the necessary or 
therapeutically active components in standard CBT approaches to excessive worry. 
Secondly, the findings in this thesis show that streamlined interventions can be 
feasible for both participants and their families, and be employed in a time-efficient 
way, meaning that they can be scalable and delivered to a broader population via 
the internet. This has been suggested as an important step in future treatment devel-
opment and improving access to evidence-based treatments (Holmes et al., 2018).
Thirdly, study I, II and IV may help to fill important knowledge gaps in the scien-
tific literature about what factors may trigger and help to maintain excessive worry 
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in both adolescents and adults. Specifically, these studies with the more narrow 
focus on a few putative mediators allow us to estimate the relative contributions 
of individual mediators to worry change in treatment. This can be contrasted to 
evaluations of standard CBT packages that in addition to providing a model of 
change (as our treatments do), include multiple interventions designed to reduce 
arousal levels generally and during worry, to modify appraisals about worry, to 
improve problem-solving skills and confidence, worry exposures, and imagery 
techniques. While such treatments have proven to be effective, it remains unclear 
which interventions are crucial to produce change. Thus, although the clinical 
effects in the studies included in this thesis are not clearly superior to previous 
findings, they can contribute to both clinicians and scientists in further understand-
ing excessive worry. 
5.3 How streamlined are the treatments?
The aim of this doctoral project was to develop and evaluate streamlined psycho-
logical interventions, but how streamlined were the treatments? 
Consistent with the IU model of excessive worry and GAD (Dugas et al., 1998), 
IU-CBT included a modified form of problem solving in addition to exposure to 
uncertainty. However, it is important to stress that problem solving in IU-CBT 
was used to elicit specific worries about practical problems, and then, by break-
ing down the problem into smaller pieces, helping the adolescent to identify the 
role that uncertainty played in triggering worries, which in turn led problems to 
be experienced as bigger and less solvable. For instance, when a patient in study I 
identified worrying about her future math grade, she identified a number of prob-
lems related to this worry (e.g. not knowing what her math homework was, not 
being able to concentrate on math in a crowded classroom). Once these problems 
were identified, solving them was encouraged as an exposure to uncertainty in 
itself (as she then started worrying about how her teacher would perceive her when 
she raised questions about the problems). Thus, while IU-CBT included ‘problem 
solving’ exercises, their aim (like the rest of the treatment) was to increase aware-
ness about the role of uncertainty in bouts of excessive worry, and that ultimately, 
it was planned confrontations with uncertainty which would lead to a reduction in 
worry – not increased problem-solving confidence or skill. 
With respect to I-MCT, the treatment included interventions that targeted other con-
structs than negative beliefs about worry, including attention training and positive 
beliefs about worry. However, attention training as used in I-MCT was intended 
to help participants become more aware of their beliefs about the extent to which 
their own worries were dangerous and uncontrollable, not as a strategy to divert 
themselves from worrying or to reduce the intensity of worries when they occurred. 
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Still, it is possible that attention training, separate from any change in appraisals 
about worry, has by itself a significant impact on the frequency and content of 
worry, as has been suggested in the literature (Hayes, Hirsch, & Mathews, 2008; 
Hirsch & Mathews, 2012).
With respect to positive beliefs about worry, it has been suggested that these may 
be less common and less influential than negative beliefs about worry (Penney, 
Mazmanian, & Rudanycz, 2013; Ruscio & Borkovec, 2004). Thus, it is arguable 
whether I-MCT needed to include standard cognitive interventions to modify posi-
tive beliefs about worry and/or whether changes in these beliefs also mediated 
outcomes in study IV. As previously suggested, one recommendation for future 
trials is therefore to randomize participants to three conditions, and again provide 
different levels of the intervention targeting the proposed mechanism of change 
(i.e. either negative or positive beliefs about worry) to each condition to explore 
the causal impact of positive beliefs about worry. Dismantling trials could also 
provide important knowledge about the need for interventions targeting positive 
beliefs about worry in treatment (Kazdin, 2007).  
5.4 How should we involve the context?
I personally believe that an important aim in the development of more effective 
psychotherapies is to streamline (i.e., reduce to absolute minimum necessary) the 
number of interventions included in the treatment and at the same to define the 
limits under which these therapies can be effectively delivered. I wanted to take 
a step in that direction with IU-CBT for adolescents, by developing a treatment 
that could be delivered online, and included a limited number of interventions 
aimed at the adolescent, with parallel interventions (modules) for parents. Meta-
analyses have not been able to show any incremental effects on anxiety (benefits 
do accrue in terms of comorbid behavior problems) of parental involvement in the 
treatment of pediatric anxiety (Breinholst, Esbjørn, Reinholdt-Dunne, & Stallard, 
2012; Thulin, Svirsky, Serlachius, Andersson, & Öst, 2014). However, few studies 
are actually designed to test whether parental involvement adds to the treatment 
effect (Thulin et al., 2014). Research has also found that accommodation to anxi-
ety symptoms is common in families of children and adolescents with anxiety 
disorders (Benito et al., 2015; Lebowitz et al., 2013; Thompson-Hollands, Kerns, 
Pincus, & Comer, 2014), and that it may negatively impact the course of illness 
and treatment outcomes (Norman, Silverman, & Lebowitz, 2015). Parental accom-
modation was significantly reduced after treatment with IU-CBT, and in study III, 
both adolescents and parents highlighted the importance of parental involvement 
for the adolescents’ adherence to treatment. Nevertheless, further studies are needed 
where internet-based treatments with and without parental involvement are tested, 
and attempts to identify child- and parent-level moderators that help to explain 
which treatment approach works best for which patient and parent.
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Likewise, research is needed to determine whether treatments like IU-CBT can be 
feasibly and effectively delivered in primary and specialist care clinics where the 
organizational structures are built around the delivery of face-to-face treatments. 
A previous implementation study of internet-delivered CBT for pediatric anxiety 
within a specialist care clinic in rural Sweden (Jolstedt, Ljótsson, et al., 2018) 
identified important challenges even though clinicians were positive to the online 
format. Subsequently, implementation with training and supervision of clinicians 
needs further investigation. In study III, several adolescents and parents described 
having experienced a need for more therapist support. Previous studies with adults 
have shown superior treatment outcomes for therapist-guided compared to unguided 
internet-delivered treatments (Baumeister, Reichler, Munzinger, & Lin, 2014) but 
future studies need to further evaluate how the frequency and method of support 
can be tailored to individual needs, and if that can improve clinical outcomes.
Finally, new research has suggested a streamlined focus on IU as a way of improving 
treatment outcomes for adults with GAD (Hebert & Dugas, 2019), and that group-
MCT can produce effects on worry for adolescents with anxiety and depression 
similar to those reported in studies I and II in this thesis (Thorslund, McEvoy, & 
Anderson, 2020). Future studies could build on this new research and the results 
presented in this thesis and develop streamlined, internet-delivered IU-CBT for 
adults as well as internet-delivered MCT for adolescents.
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6 CONCLUSIONS
Focusing on IU for adolescents with excessive worry is feasible and potentially 
effective, and both adolescents and their parents found the treatment to be both 
challenging and valuable. I-MCT appears to be a feasible, acceptable, and effective 
treatment when delivered in an online format to adults with excessive worry, with 
changes in negative beliefs about worry mediating changes in worry outcomes 
(and more so than changes in depression). Future research should aim to replicate 
the current findings under randomized controlled conditions with adolescents, 
and with an active control for adults. We also need studies across this age range 
that include tests of moderation, mediation, and moderated mediation, to better 
establish causal mechanisms in the treatments and which treatments work best for 
which patients. If we better understand how treatments work and for whom, even 
more streamlined, scalable and effective treatments for adolescents and adults 
can be developed.
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